Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy has demonstrated positive momentum in its commercial pricing, achieving a sequential increase of 2.2%, with the potential for a 3% rise if not for specific issues in Michigan. Additionally, the company's Industrial Injury Prevention (IIP) revenue exhibited substantial growth of 22.2% overall, and 18.4% when excluding contributions from mergers and acquisitions, indicating strong underlying demand for its services. Furthermore, the recent acquisition of the Metro business has resulted in an increase in the current net rate from approximately $101 to $107.50, reflecting effective integration and value extraction from new assets.

Bears say

US Physical Therapy's stock outlook is negatively impacted by a consistent decline in reimbursement rates, which have led to a $20 million cumulative headwind to profitability over the past five years. Additionally, operating expenses, particularly rent and other costs, have risen to 20.2% of revenue, marginally exceeding initial estimates, which indicates increased operational pressure. Despite a slight increase in other revenue, the ongoing reimbursement cuts and rising costs suggest significant challenges that could affect future profitability and overall financial performance.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $107.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $107.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.